Steiner, B.; Edmond, A.; Camou, M.; Praska, T.; Niu, J.
Osimertinib-Induced Hepatitis Following Immunotherapy in a Patient with Lung Adenocarcinoma Harboring De Novo EGFR Exon 19 Deletion and T790M Mutations: A Case Report. Reports 2025, 8, 101.
https://doi.org/10.3390/reports8030101
AMA Style
Steiner B, Edmond A, Camou M, Praska T, Niu J.
Osimertinib-Induced Hepatitis Following Immunotherapy in a Patient with Lung Adenocarcinoma Harboring De Novo EGFR Exon 19 Deletion and T790M Mutations: A Case Report. Reports. 2025; 8(3):101.
https://doi.org/10.3390/reports8030101
Chicago/Turabian Style
Steiner, Bradley, Amanda Edmond, Monica Camou, Taylor Praska, and Jiaxin Niu.
2025. "Osimertinib-Induced Hepatitis Following Immunotherapy in a Patient with Lung Adenocarcinoma Harboring De Novo EGFR Exon 19 Deletion and T790M Mutations: A Case Report" Reports 8, no. 3: 101.
https://doi.org/10.3390/reports8030101
APA Style
Steiner, B., Edmond, A., Camou, M., Praska, T., & Niu, J.
(2025). Osimertinib-Induced Hepatitis Following Immunotherapy in a Patient with Lung Adenocarcinoma Harboring De Novo EGFR Exon 19 Deletion and T790M Mutations: A Case Report. Reports, 8(3), 101.
https://doi.org/10.3390/reports8030101